Investors
General Meetings/ Postal Ballot
- Investors
- General Meetings/ Postal Ballot
Annual General Meeting
Notice of 23rd Annual General Meeting
Notice of 22nd Annual General Meeting of MHIL
Notice of 21st Annual General Meeting of MHIL
Notice for 20th Annual General Meeting of MHIL
Notice for 19th Annual General Meeting of MHIL
18th Annual General Meeting
17th Annual General Meeting
16th Annual General Meeting
15th Annual General Meeting
Annual General Meeting 2015
Annual Return
Minutes of 23rd Annual General Meeting
Transcript of 23rd Annual General Meeting
Summary of Proceedings of 23rd Annual General Meeting
Voting Results and Scrutinizer’s Report for 23rd Annual General Meeting
Notice under Section 160 of the Companies Act, 2013
Newspaper Publication - Notice of 23rd Annual General Meeting and E-Voting Information
Business Responsibility and Sustainability Report
Disclosure pursuant to SEBI (SBEB & SE) Regulations, 2021
Newspaper Publication - Information regarding 23rd AGM, Dividend and Record Date
Minutes of Annual General Meeting
Max Healthcare – Transcript of 22nd AGM
Voting Results and Scrutinizer’s Report – 22nd AGM
Proceeding of AGM-September 27, 2023
Newspaper Publication – Notice of 22nd Annual General Meeting and E-voting information
Newspaper Publication - Information regarding 22nd Annual General Meeting and Record Date
2022-23
Disclosure pursuant to SEBI (SBEB & SE) Regulations, 2021
Business Responsibility and Sustainability Report 2022-23
2022-23
Newspaper Advertisement for Notice of 19th AGM
Max Healthcare - 21st AGM Script
Voting results and Scrutinizer Report - 21 AGM
Proceeding of AGM-September 26, 2022
Newspaper Advertisement –Notice of 21st AGM
Newspaper Advertisement – Intimation of 21st AGM/ Email Registration
2021-22
2021-22
Max Healthcare - 20th AGM Script
Voting Result & Scrutnizer's Report- 20th AGM
Proceeding of AGM-September 29, 2021
Newspaper Advertisement - Notice of 20th AGM
Newspaper Advertisement – Intimation of 20th AGM/ Email Registration
2020-21
2020-21
MHIL Intimation for Change in Date of 20th AGM
Voting result & Scrutinizer’s Report- AGM
Proceeding of AGM-September 29, 2020
Intimation regarding AGM timings
Newspaper Advertisement for Email Registration
Extract Anual Return
2019-20
2018-19
2018-19
2017-18
2017-18
2015-16
2015-16
2014-15
Integrated Annual Report 2023 - 24
Annual Report 2022-23 Spread view
Annual Report 2021-22 Spread view
Annual Report 2022-23 - Single page view
Annual Report 2021-22 - Single page view
Annual Report 2020-21 - Spread view
Annual Report 2020-21 - Single page view
Annual Report 2018-19
Annual Report 2014-15
Annual Report 2019-20 - Spread view
Annual Report 2019-20 - Single page view
Annual Report 2017-18
Annual Report 2016-17
Annual Report 2015-16
Postal Ballot
Extra Ordinary General Meeting
Resolution Summary
No. of shares outstanding: | 971,925,962 |
|
||||||
---|---|---|---|---|---|---|---|---|
Particulars | Types of resolution | Outcome | Votes polled as % of shares outstanding |
|
||||
Adoption of Audited Standalone Financial Statements for the financial year 2023-24 | Ordinary | Passed | 90.109% |
|
||||
Adoption of Audited Consolidated Financial Statements for the financial year 2023-24 | Ordinary | Passed | 90.109% |
|
||||
Declaration of final Dividend of ₹1.5 (i.e. 15%) per equity share of face value of ₹ 10 each | Ordinary | Passed | 90.189% |
|
||||
Appointment of director in place of Mr. Narayan K. Seshadri, who retires by rotation and being eligible offers himself for re-appointment | Ordinary | Passed | 90.185% |
|
||||
Appointment of Dr. Pranav C. Mehta as an Independent Director of the Company | Special | Passed | 90.022% |
|
||||
Ratification of remuneration payable to Cost Auditors for the financial year 2024-25 | Ordinary | Passed | 90.133% |
|
No. of shares outstanding: | 971,417,233 |
|
||||||
---|---|---|---|---|---|---|---|---|
Particulars | Types of resolution | Outcome | Votes polled as % of shares outstanding |
|
||||
Re-appointment of Mr. Michael Thomas Neeb as an Independent Director of the Company | Special | Passed | 89.000% |
|
||||
Re-appointment of Mr. Mahendra Gumanmalji Lodha as an Independent Director of the Company | Special | Passed | 89.000% |
|
No. of shares outstanding | 971,580,320 |
|
||||||
---|---|---|---|---|---|---|---|---|
Particulars | Types of resolution | Outcome | Votes polled as % of shares outstanding |
|
||||
Adoption of Audited Standalone Financial Statements for the financial year ended March 31, 2023 together with the reports of board of directors and auditor’s thereon | Ordinary | Passed | 89.933% |
|
||||
Adoption of Audited Consolidated Financial Statements for the financial year ended March 31, 2023 together with the report of the auditor’s thereon | Ordinary | Passed | 89.933% |
|
||||
Declaration of final Dividend of ₹ 1 (i.e. 10%) per equity share of face value of ₹ 10 each | Ordinary | Passed | 89.965% |
|
||||
Appointment of Director in place of Mr. Anil Kumar Bhatnagar, who retires by rotation and being eligible, offers himself for re-appointment | Ordinary | Passed | 89.936% |
|
||||
Fixation of tenure of Mr. Anil Kumar Bhatnagar, Non-Executive Director for 3 (three) years | Ordinary | Passed | 89.965% |
|
||||
Appointment of Ms. Amrita Gangotra as an Independent Director of the Company for a term of 5 (five) consecutive years | Special | Passed | 89.936% |
|
||||
Payment of remuneration to Ms. Amrita Gangotra as an Independent Director of the Company | Ordinary | Passed | 89.965% |
|
||||
Increase in remuneration of Non-Executive Directors (including Independent Directors) | Ordinary | Passed | 89.965% |
|
||||
One-time Performance Bonus to Mr. Abhay Soi, Chairman and Managing Director | Special | Passed | 88.987% |
|
||||
Approval for alteration in Articles of Association of the Company | Special | Passed | 89.965% |
|
||||
Ratification of remuneration payable to Cost Auditors for the financial year 2023-24 | Ordinary | Passed | 89.965% |
|
No. of shares outstanding: | 971,417,233 |
|
||||||
---|---|---|---|---|---|---|---|---|
Particulars | Types of resolution | Outcome | Votes polled as % of shares outstanding |
|
||||
Appointment of Mr. Narayan K. Seshadri as Non-Executive and Non-Independent Director | Ordinary | Passed | 89.081% |
|
||||
Payment of remuneration to Mr. Narayan K. Seshadri as Non-Executive and Non-Independent Director | Ordinary | Passed | 89.081% |
|
No. of shares outstanding: | 969,677,260 |
|
||||||
---|---|---|---|---|---|---|---|---|
Particulars | Types of resolution | Outcome | Votes polled as % of shares outstanding |
|
||||
To receive, consider and adopt (a) the audited standalone financial statements of the Company for the financial year ended March 31, 2022 together with the reports of Board of Directors and Auditor’s thereon; and (b) the audited consolidated financial statements of the Company for the financial year ended March 31, 2022 together with the report of the Auditor’s thereon. | Ordinary | Passed | 88.452% |
|
||||
To note that Mr. Prashant Kumar (DIN-08342577), Non-Executive Non Independent Director, liable to retire by rotation, does not seek re-election as a Director of the Company. | Ordinary | Passed | 88.442% |
|
||||
Appointment of Mr. Anil Bhatnagar (DIN-09716726) as Non-Executive Non Independent Director in place of Mr. Prashant Kumar (DIN-08342577), liable to retire by rotation. | Ordinary | Passed | 88.463% |
|
||||
Payment of Remuneration to Mr. Anil Bhatnagar (DIN-09716726) on appointment as Non-Executive Non-Independent Director of the Company | Special | Passed | 88.421% |
|
||||
Ratification of remuneration of Cost Auditor for the financial year 2022-23. | Ordinary | Passed | 88.462% |
|
||||
Re-appointment of Mr. Abhay Soi (DIN-00203597) as Chairman and Managing Director of the Company | Ordinary | Passed | 88.268% |
|
||||
Payment of remuneration to Mr. Abhay Soi (DIN-00203597) on re- appointment as Chairman and Managing Director of the Company. | Special | Passed | 88.421% |
|
||||
Appointment of Mr. Pranav Amin (DIN-00245099) as Non-Executive Independent Director of the Company. | Special | Passed | 88.421% |
|
||||
Payment of remuneration to Mr. Pranav Amin (DIN-00245099) on appointment as Non-Executive Independent Director of the Company. | Special | Passed | 88.463% |
|
||||
Approval of ‘Max Healthcare Institute Limited - Employee Stock Option Plan 2022’ and grant of employee stock options to the eligible employees of the Company. | Special | Passed | 87.327% |
|
||||
Grant of employee stock options under the ‘Max Healthcare Institute Limited - Employee Stock Option Plan 2022’ to the employees of the Holding Company, if any, and/or Subsidiary Company (ies) of the Company. | Special | Passed | 87.327% |
|
||||
Revise the limit to make loan(s) or give guarantee(s) or provide security (ies) or make investment(s) in excess of the prescribed limit under Section 186 of the Companies Act, 2013 read with the rules made thereunder. | Special | Passed | 88.421% |
|
||||
Revise borrowing limit under Section 180(1)(c) of the Companies Act, 2013. | Special | Passed | 88.421% |
|
||||
Revise limit under Section 180(1)(a) of the Companies Act, 2013, for creation of charge on the assets of the Company, both present and future, in respect of its borrowings. | Special | Passed | 88.421% |
|
No. of shares outstanding: | 969,613,455 |
|
||||||
---|---|---|---|---|---|---|---|---|
Particulars | Types of resolution | Outcome | Votes polled as % of shares outstanding |
|
||||
Appointment of Mr. Prashant Kumar (DIN-08342577) as Non-Executive Non Independent Director of the Company | Ordinary | Passed | 89.284% |
|
||||
Appointment of Mr. Gaurav Trehan (DIN - 03467781) as Non-Executive Non Independent Director of the Company | Ordinary | Passed | 89.284% |
|
No. of shares outstanding: | 965,945,006 |
|
||||||
---|---|---|---|---|---|---|---|---|
Particulars | Types of resolution | Outcome | Votes polled as % of shares outstanding |
|
||||
Approval of public shareholders of the Company for amending certain provisions of the Shareholders’ Agreement dated December 24, 2018 executed amongst Mr. Abhay Soi (as Promoter) and Kayak Investments Holding Pte. Ltd. (“Kayak”/”Investor”) and in respect of which the Deed of Accession and Adherence was executed by the Company on June 1, 2020 (“Post Merger SHA”), in particular those relating to the Upside Share and Early Exit Upside Share from the Investor to the Promoter pursuant to Regulation 2 | Ordinary | Passed | 28.338% |
|
||||
Approval for amendments to Articles of Association of the Company pursuant to the Second Letter Amendment Agreement dated September 28, 2021 to Post Merger SHA | Ordinary | Passed | 89.239% |
|
No. of shares outstanding: | 965,945,006 |
|
||||||
---|---|---|---|---|---|---|---|---|
Particulars | Types of resolution | Outcome | Votes polled as % of shares outstanding |
|
||||
To receive, consider and adopt: a. the audited standalone financial statements of the Company for the financial year ended March 31, 2021 together with Reports of the Board of Directors and Auditors thereon; and b. the audited consolidated financial statements of the Company for the financial year ended March 31, 2021 together with the report of the Auditors thereon. | Ordinary | Passed | 89.744% |
|
||||
To appoint a Director in place of Ms. Ananya Tripathi (DIN: 08102039) who retires by rotation and being eligible, offers herself for re-appointment | Ordinary | Passed | 89.303% |
|
||||
Ratification of remuneration of Cost Auditors for the financial year 2021-22. | Ordinary | Passed | 89.772% |
|
||||
Appointment of Ms. Harmeen Mehta (DIN: 02274379) as an Independent Director of the Company. | Ordinary | Passed | 89.303% |
|
||||
Remuneration to Independent Directors. | Special | Passed | 89.303% |
|
No. of shares outstanding: | 965,945,006 |
|
||||||
---|---|---|---|---|---|---|---|---|
Particulars | Types of resolution | Outcome | Votes polled as % of shares outstanding |
|
||||
To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2020, together with the Reports of the Board of Directors and Auditors thereon and the audited consolidated financial statements of the Company for the financial year ended March 31, 2020 together with the report of the Auditors thereon. | Ordinary | Passed | 87.027% |
|
||||
To appoint a Director in place of Mr. Sanjay Omprakash Nayar (DIN-00002615) who retires by rotation and being eligible, offers himself for re-appointment. | Ordinary | Passed | 86.637% |
|
||||
To appoint M/s Deloitte Haskins & Sells, Chartered Accountants as the Statutory Auditors of the Company, from the conclusion of this Annual General Meeting till the conclusion of 24th Annual General Meeting. | Ordinary | Passed | 87.039% |
|
||||
To Ratify remuneration payable to M/s Chandra Wadhwa & Co., Cost Accountants for the Financial Year ending March 31, 2021. | Ordinary | Passed | 87.039% |
|
||||
To approve ‘Max Healthcare Institute Limited - Employee Stock Option Plan 2020’ and grant employee stock options to the eligible employees of the Company. | Special | Passed | 87.039% |
|
||||
To Grant employee stock options under the ‘Max Healthcare Institute Limited - Employee Stock Option Plan 2020’ to the employees of the Holding Company, if any, and/or Subsidiary Company (ies) of the Company. | Special | Passed | 87.039% |
|
||||
To issue Securities to Qualified Institutional Buyers. | Special | Passed | 87.039% |
|
||||
To issue Non-Convertible Debentures (“NCDs”) on Private Placement basis. | Special | Passed | 87.039% |
|
||||
To increase the Authorized Share Capital of the Company. | Ordinary | Passed | 87.039% |
|